• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗结核药物性肝损伤的蒙汉人群肠道微生物特征:基于人群的病例对照研究。

Gut microbiota characteristics of Mongolian and Han populations in anti-tuberculosis drug-induced liver injury: a population-based case-control study.

机构信息

School of Public Health, North China University of Science and Technology, Hebei Province, 063210, Tangshan, China.

School of Public Health, Baotou Medical College, Inner Mongolia, 014030, Baotou, China.

出版信息

BMC Microbiol. 2023 Mar 16;23(1):74. doi: 10.1186/s12866-023-02801-4.

DOI:10.1186/s12866-023-02801-4
PMID:36927469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10018964/
Abstract

BACKGROUND

The pathogenesis of anti-tuberculosis (TB) drug-induced liver injury (ADLI) is complicated and remains unclear. We aimed to analyse the relationship between the characteristics of gut microbiota and ADLI in Mongolian and Han patients with pulmonary TB and identify the most notable bacteria related to the occurrence of liver injury in those populations.

METHODS

Patients with concurrent liver injury (LI) and no liver injury (ULI) before receiving first-line anti-TB drug treatment (T1) from the Han population in Tangshan and the Mongolian population in Inner Mongolia were selected as research subjects. At the time of liver injury (T2), stool samples were measured by bacterial 16S rRNA gene high-throughput sequencing to analyse and compare the differences in the gut microbiota of the LI and ULI Mongolian and Han patients at T1 and T2 and identify the differences between those patients.

RESULTS

A total of 45 Mongolian and 37 Han patients were enrolled in our study. A dynamic comparison from T1 to T2 showed that the microbiota of the LI and ULI groups changed significantly from T1 to T2 in both the Mongolian and Han populations. However, there were commonalities and personality changes in the microbiota of the two ethnic groups.

CONCLUSION

Differences in gut microbes in ADLI were found among the Han and Mongolian patients in our study. Ekmania and Stenotrophomonas were related to the occurrence of ADLI in Mongolian patients, while Ekmania and Ruminococcus__gnavus_group were related to the occurrence of ADLI in the Han population.

摘要

背景

抗结核(TB)药物性肝损伤(ADLI)的发病机制复杂,尚不清楚。我们旨在分析蒙古和汉族肺结核患者肠道微生物群特征与 ADLI 的关系,并确定与这两个人群肝损伤发生最相关的最显著细菌。

方法

选择来自唐山汉族人群和内蒙古蒙古族人群的一线抗结核药物治疗前合并肝损伤(LI)和无肝损伤(ULI)的患者作为研究对象。在肝损伤时(T2),通过细菌 16S rRNA 基因高通量测序测量粪便样本,以分析和比较 T1 时 LI 和 ULI 蒙古和汉族患者肠道微生物群的差异,并确定这些患者之间的差异。

结果

本研究共纳入 45 例蒙古族和 37 例汉族患者。从 T1 到 T2 的动态比较显示,LI 和 ULI 组的微生物群在蒙古族和汉族人群中均从 T1 到 T2 发生了显著变化。然而,两组的微生物群存在共性和个性变化。

结论

本研究发现汉族和蒙古族 ADLI 患者的肠道微生物群存在差异。在蒙古族患者中,Ekmania 和 Stenotrophomonas 与 ADLI 的发生有关,而在汉族人群中,Ekmania 和 Ruminococcus__gnavus_group 与 ADLI 的发生有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/41cdbf99dca7/12866_2023_2801_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/e5daf3755361/12866_2023_2801_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/cb62ff683b67/12866_2023_2801_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/67cb0ed0b983/12866_2023_2801_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/b60887d86c1c/12866_2023_2801_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/09e2c88446e7/12866_2023_2801_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/c5a72df1ee3b/12866_2023_2801_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/097f82293e05/12866_2023_2801_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/c956234e3646/12866_2023_2801_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/41cdbf99dca7/12866_2023_2801_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/e5daf3755361/12866_2023_2801_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/cb62ff683b67/12866_2023_2801_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/67cb0ed0b983/12866_2023_2801_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/b60887d86c1c/12866_2023_2801_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/09e2c88446e7/12866_2023_2801_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/c5a72df1ee3b/12866_2023_2801_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/097f82293e05/12866_2023_2801_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/c956234e3646/12866_2023_2801_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ed/10018964/41cdbf99dca7/12866_2023_2801_Fig9_HTML.jpg

相似文献

1
Gut microbiota characteristics of Mongolian and Han populations in anti-tuberculosis drug-induced liver injury: a population-based case-control study.抗结核药物性肝损伤的蒙汉人群肠道微生物特征:基于人群的病例对照研究。
BMC Microbiol. 2023 Mar 16;23(1):74. doi: 10.1186/s12866-023-02801-4.
2
Comparative analysis of type 2 diabetes-associated gut microbiota between Han and Mongolian people.汉族与蒙古族 2 型糖尿病患者肠道微生物的比较分析。
J Microbiol. 2021 Jul;59(7):693-701. doi: 10.1007/s12275-021-0454-8. Epub 2021 May 15.
3
Involvement of cytochrome P450 1A1 and glutathione S-transferase P1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: a case-control study.细胞色素P450 1A1和谷胱甘肽S-转移酶P1基因多态性及启动子高甲基化与抗结核药物性肝损伤进展的关系:一项病例对照研究
PLoS One. 2015 Mar 23;10(3):e0119481. doi: 10.1371/journal.pone.0119481. eCollection 2015.
4
Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study.中国抗结核治疗结核病患者肠道微生物组的纵向分析:一项前瞻性队列研究方案。
BMC Pulm Med. 2019 Nov 11;19(1):211. doi: 10.1186/s12890-019-0981-9.
5
Interaction between the HIF-1α gene rs1957757 polymorphism and CpG island methylation in the promoter region is associated with the risk of anti-tuberculosis drug-induced liver injury in humans: A case-control study.HIF-1α 基因 rs1957757 多态性与启动子区 CpG 岛甲基化之间的相互作用与人类抗结核药物性肝损伤的风险相关:一项病例对照研究。
J Clin Pharm Ther. 2022 Jul;47(7):948-955. doi: 10.1111/jcpt.13625. Epub 2022 Feb 26.
6
The role of NAT2 polymorphism and methylation in anti-tuberculosis drug-induced liver injury in Mongolian tuberculosis patients.NAT2基因多态性和甲基化在蒙古族肺结核患者抗结核药物性肝损伤中的作用
J Clin Pharm Ther. 2020 Jun;45(3):561-569. doi: 10.1111/jcpt.13097. Epub 2019 Dec 10.
7
Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment.肺结核患者抗结核治疗中肠道微生物群落失调。
Microbiol Spectr. 2021 Dec 22;9(3):e0061521. doi: 10.1128/spectrum.00615-21. Epub 2021 Dec 15.
8
[Gut microbiota in Tibetan, Mongolian and Zhuang children aged 10-12 years old in 2016].2016年10至12岁藏族、蒙古族和壮族儿童的肠道微生物群
Wei Sheng Yan Jiu. 2022 May;51(3):411-416. doi: 10.19813/j.cnki.weishengyanjiu.2022.03.011.
9
Alterations of gut microbiota in patients with active pulmonary tuberculosis in China: a pilot study.中国活动性肺结核患者肠道微生物群的改变:一项初步研究。
Int J Infect Dis. 2021 Oct;111:313-321. doi: 10.1016/j.ijid.2021.08.064. Epub 2021 Sep 3.
10
Prevalence, awareness, treatment, control and risk factors related to hypertension among urban adults in Inner Mongolia 2014: differences between Mongolian and Han populations.2014年内蒙古城市成年人高血压的患病率、知晓率、治疗率、控制率及相关危险因素:蒙古族与汉族人群的差异
BMC Public Health. 2016 Apr 1;16:294. doi: 10.1186/s12889-016-2965-5.

引用本文的文献

1
The association between the gut microbiome and antituberculosis drug-induced liver injury.肠道微生物群与抗结核药物性肝损伤之间的关联。
Front Pharmacol. 2025 Mar 10;16:1512815. doi: 10.3389/fphar.2025.1512815. eCollection 2025.
2
Drug Induced Liver Injury: Highlights and Controversies in the 2023 Literature.药物性肝损伤:2023年文献综述的重点与争议
Drug Saf. 2025 May;48(5):455-488. doi: 10.1007/s40264-025-01514-z. Epub 2025 Feb 8.

本文引用的文献

1
The systemic anti-microbiota IgG repertoire can identify gut bacteria that translocate across gut barrier surfaces.系统抗微生物 IgG 谱可识别穿过肠道屏障表面的肠道细菌。
Sci Transl Med. 2022 Aug 17;14(658):eabl3927. doi: 10.1126/scitranslmed.abl3927.
2
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation.靶向抑制人类 IBD 相关肠道微生物共生体的噬菌体组合治疗肠道炎症。
Cell. 2022 Aug 4;185(16):2879-2898.e24. doi: 10.1016/j.cell.2022.07.003.
3
Gut microbiota is associated with metabolic health in children with obesity.
肠道微生物群与肥胖儿童的代谢健康有关。
Clin Nutr. 2022 Aug;41(8):1680-1688. doi: 10.1016/j.clnu.2022.06.007. Epub 2022 Jun 15.
4
Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity.NAT2 和 NR1I2 基因多态性与抗结核药物性肝损伤的相关性。
Xenobiotica. 2022 May;52(5):520-526. doi: 10.1080/00498254.2022.2092783. Epub 2022 Jun 29.
5
Gut microbiota, bile acids, and nature compounds.肠道微生物群、胆汁酸和天然化合物。
Phytother Res. 2022 Aug;36(8):3102-3119. doi: 10.1002/ptr.7517. Epub 2022 Jun 14.
6
The Oscillating Gut Microbiome and Its Effects on Host Circadian Biology.肠道微生物群的摆动及其对宿主昼夜节律生物学的影响。
Annu Rev Nutr. 2022 Aug 22;42:145-164. doi: 10.1146/annurev-nutr-062320-111321. Epub 2022 May 16.
7
Metformin Mitigates Sepsis-Related Neuroinflammation Modulating Gut Microbiota and Metabolites.二甲双胍通过调节肠道微生物群和代谢物减轻脓毒症相关的神经炎症。
Front Immunol. 2022 Apr 29;13:797312. doi: 10.3389/fimmu.2022.797312. eCollection 2022.
8
Metformin attenuated sepsis-related liver injury by modulating gut microbiota.二甲双胍通过调节肠道微生物群减轻脓毒症相关的肝损伤。
Emerg Microbes Infect. 2022 Dec;11(1):815-828. doi: 10.1080/22221751.2022.2045876.
9
[Association between isoniazid induced hepatotoxicity and host N-acetyltransferase 2 polymorphisms].异烟肼诱导的肝毒性与宿主N-乙酰转移酶2基因多态性之间的关联
Zhonghua Jie He He Hu Xi Za Zhi. 2022 Feb 12;45(2):227-232. doi: 10.3760/cma.j.cn112147-20210610-00413.
10
Role of the gut microbiome in cardiovascular drug response: The potential for clinical application.肠道微生物组在心血管药物反应中的作用:临床应用的潜力。
Pharmacotherapy. 2022 Feb;42(2):165-176. doi: 10.1002/phar.2650. Epub 2021 Dec 7.